Redpoint Investment Management’s Teva Pharmaceuticals TEVA Stock Holding History

Redpoint Investment Management’s Portfolio TEVA Stock Details TEVA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q3	$147K	Hold	18,252	–	–	0.02%	571
2022 Q2	$137K	Hold	18,252	–	–	0.02%	602
2022 Q1	$171K	Hold	18,252	–	–	0.02%	617
2021 Q4	$146K	Hold	18,252	–	–	0.01%	641
2021 Q3	$178K	Hold	18,252	–	–	0.02%	641
2021 Q2	$181K	Hold	18,252	–	–	0.01%	662
2021 Q1	$211K	Buy	+18,252	New	+$209K	0.02%	638
2020 Q4	–	Sell	-19,695	Closed	-$177K	–	630
2020 Q3	$177K	Sell	19,695 -2,244	-10%	-$23.7K	0.02%	561
2020 Q2	$271K	Hold	21,939	–	–	0.02%	509
2020 Q1	$197K	Hold	21,939	–	–	0.01%	527
2019 Q4	$215K	Hold	21,939	–	–	0.01%	584
2019 Q3	$151K	Sell	21,939 -45,357	-67%	-$348K	0.01%	585
2019 Q2	$621K	Hold	67,296	–	–	0.03%	425
2019 Q1	$1.05M	Buy	67,296 +6,338	+10%	+$112K	0.05%	376
2018 Q4	$940K	Hold	60,958	–	–	0.05%	367
2018 Q3	$1.31M	Hold	60,958	–	–	0.07%	334
2018 Q2	$1.48M	Hold	60,958	–	–	0.08%	304
2018 Q1	$1.04M	Hold	60,958	–	–	0.06%	352
2017 Q4	$1.16M	Buy	+60,958	New	+$917K	0.06%	345

Other funds holding TEVA

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

ACM

Abrams Capital Management Boston, Massachusetts $4.64B AUM 1.52% 1-Year Est. Return

MMH

Menora Mivtachim Holdings Ramat Gan, Israel $21.1B AUM 40.03% 1-Year Est. Return

MIFH

Migdal Insurance & Financial Holdings Petach Tikva, Israel $11.5B AUM 52.5% 1-Year Est. Return

Phoenix Financial Givatayim, Israel $10.5B AUM 49.21% 1-Year Est. Return

Clal Insurance Tel-Aviv, Israel $16.6B AUM 68.34% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

HIIFS

Harel Insurance Investments & Financial Services Ramat Gan, Israel $14.7B AUM 47% 1-Year Est. Return

Redpoint Investment Management's TEVA Position: Q3 2022 in Review

Redpoint Investment Management held its Teva Pharmaceuticals (TEVA) position steady in Q3 2022 at 18,252 shares worth $147K. The position accounts for 0.02% of the portfolio, ranked #571.

Redpoint Investment Management first reported a position in TEVA in Q4 2017 and has held it in 19 quarters since. The position peaked at $1.48M in Q2 2018. 430 funds tracked by Wall St. Rank hold TEVA as of Q3 2022.

Redpoint Investment Management held 18,252 shares of Teva Pharmaceuticals worth $147K as of Q3 2022.
Redpoint Investment Management left its Teva Pharmaceuticals share count unchanged in Q3 2022.
Teva Pharmaceuticals made up 0.02% of Redpoint Investment Management's portfolio in Q3 2022, its #571 holding.
Redpoint Investment Management first reported a position in Teva Pharmaceuticals in Q4 2017 and has held it in 19 quarters since.
Redpoint Investment Management's Teva Pharmaceuticals position peaked at $1.48M in Q2 2018.
430 funds tracked by Wall St. Rank held Teva Pharmaceuticals as of Q3 2022.

Based on Redpoint Investment Management's 13F filing for Q3 2022, filed 14 Oct 2022.